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Abstract
Background: Forward-time simulations have unique advantages in power and flexibility for the simulation of
genetic samples of complex human diseases because they can closely mimic the evolution of human populations
carrying these diseases. However, a number of methodological and computational constraints have prevented the
power of this simulation method from being fully explored in existing forward-time simulation methods.
Results: Using a general-purpose forward-time population genetics simulation environment, we developed a
forward-time simulation method that can be used to simulate realistic samples for genome-wide association
studies. We examined the properties of this simulation method by comparing simulated samples with real data
and demonstrated its wide applicability using four examples, including a simulation of case-control samples with a
disease caused by multiple interacting genetic and environmental factors, a simulation of trio families affected by a
disease-predisposing allele that had been subjected to either slow or rapid selective sweep, and a simulation of a
structured population resulting from recent population admixture.
Conclusions: Our algorithm simulates populations that closely resemble the complex structure of the human
genome, while allows the introduction of signals of natural selection. Because of its flexibility to generate different
types of samples with arbitrary disease or quantitative trait models, this simulation method can simulate realistic
samples to evaluate the performance of a wide variety of statistical gene mapping methods for genome-wide
association studies.
Background
Simulated data sets of known disease-predisposing loci
(DPL) have been widely used in the development and
application of statistical methods that detect susceptibil-
ity genes for human genetic diseases [1,2]. Whereas sim-
ple samples simulated under idealized assumptions can
be used to validate properties of statistical gene mapping
methods, only samples that reflect the complex struc-
ture of the human genome and the genetic basis of
human genetic diseases can be used to evaluate and
compare the statistical power of these methods and to
compare various sampling designs under realistic condi-
tions. Otherwise, a gene mapping method may perform
well in theory and on simulated datasets, but poorly on
real datasets [3,4].
Thanks to rapid advances in genotyping technology,
genome-wide association studies (GWAS) have been
increasingly used to decipher multiple interacting
genetic and environmental factors that are responsible
for complex human diseases [5,6]. The increased use of
GWAS has fostered the development of statistical meth-
ods and software applications for the simulation of
genetic samples with high-density markers over long
genome regions [7]. Such simulations have been used to
compare the power of popular study designs and
statistical methods for GWA studies [8-10], to simulate
case-control samples for evaluating the power of new
statistical methods [11], and to study the performance
of statistical tests under different disease models [12,13].
Several programs have been developed to simulate
g e n e t i cd a t af o rG W A S .E x c l u ding specialized methods
that simulate genetic data for particular types of samples,
currently available simulation methods can be categor-
ized roughly as resampling-based [9,14,15], backward-
time-based (coalescent) [16-18], and forward-time-based
[19-21]. Resampling methods permute or sample from
existing genome sequences. Although these methods
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brium (LD) information from existing sequences, they
are limited in their ability to introduce new genetic fea-
tures (such as the effects of natural selection) and new
haplotypes. For example, from a sample of 20,000 simu-
lated sequences of 40 tightly linked markers over a
100-kbp region on chromosome 17 that we simulated
u s i n gH A P G E N[ 9 ] ,o n l y7 4u n i q u eh a p l o t y p e se x i s t
because all the haplotypes are derived from the 63 unique
haplotypes that exist in the European HapMap sample
(CEU) [22] using an imputation approach.
Coalescent methods excel at simulating random sam-
ples, but it is difficult to use these methods to simulate
case-control or other types of samples with genetic dis-
eases because a coalescent simulation constructs a gen-
ealogical tree from samples with unknown genotypes
and cannot effectively control the number of affected
individuals once the genotypes of these samples are
simulated [23,24]. If a large number of samples are
simulated before a disease model is applied, the coales-
cent method becomes inefficient, especially when long
genomic sequences are simulated, unless special algo-
rithms are used to approximate the standard coalescent
process [25-27]. In addition, many coalescent method-
based programs simulate samples with random marker
locations, which makes defining a genetic disease with
consistent DPL difficult. Finally, most of these methods
were designed to simulate case-control samples of rela-
tively simple disease models and therefore have limited
applicability to important research areas such as the
detection of gene-environment interaction, admixture
mapping, or family-based associations.
Forward-time simulation methods evolve a population
forward in time, subject to arbitrary genetic and demo-
graphic factors. Because such a simulation can closely
mimic the complex evolutionary histories of human
populations that harbor the genetic diseases of interest,
these methods can, in theory, simulate genetic samples
with arbitrary complexity. Arbitrary disease models
could be applied to the resulting population from which
samples based on different study designs can be drawn
and analyzed [21]. However, this method is inefficient
because ancestors who do not have offspring in the
resulting population are simulated, and a large popula-
tion must be simulated before samples can be drawn
from it. In addition, the properties of populations simu-
lated using a forward-time approach depend heavily on
the initial populations, which are often simulated under
arbitrary equilibrium assumptions. Even if the same
initial populations are used, the resulting populations
will vary because of random genetic drift. Finally, exist-
ing implementations of forward-time simulations
[19-21,28] vary in their abilities to simulate high-density
genetic markers with realistic LD patterns and none of
them can readily simulate samples that use existing
genetic markers in the human genome.
This paper presents a forward-time simulation
approach that addresses most of these problems. To
retain the complex genetic structure of human popula-
tions, this algorithm creates an initial population of
selected markers from a real sample. It then evolves this
population forward-in-time, subject to mutation, recom-
bination, natural selection, and rapid population expan-
sion. This process uses an optional scaling algorithm to
improve its performance when weak additive selection
forces are used and uses a trajectory-simulation method
to control the frequency of disease-predisposing alleles
(DPAs). Depending on specific applications, the last step
of this process involves different post-processing steps.
For example, a rejection-sampling algorithm can be
used to simulate case control samples or trio families
(affected offspring with parents) with rare diseases. We
validated the properties of this simulation method by
comparing simulated samples with real data and demon-
strated the wide applicability of this simulation method
using four examples, including a simulation of case-con-
trol samples with a disease caused by multiple interact-
ing genetic and environmental factors, a simulation of
trio families affected by a DPA that has been subject to
either slow or rapid selective sweep, and a simulation of
a structured population resulting from a recent popula-
tion admixture. The new simulation approach and all
examples were implemented using a general-purpose
forward-time population genetics simulation environ-
ment simuPOP [29], which has been used to implement
other forward-time simulations [21,30].
Methods
Because of the complexity of human genomes and their
largely unknown evolutionary histories, it is infeasible to
simulate samples that closely resemble human popula-
tions by evolving a simulated initial population. There-
fore, our simulation method uses real empirical data sets
to simulate large populations with additional genetic var-
iations while retaining key features of the empirical data
sets. Thanks to rapid advances in genotyping technology,
the genotype data of millions of single nucleotide poly-
morphism (SNP) markers of hundreds or even thousands
of individuals are currently available [6,31], and higher
density data will become available in the near future [32].
The availability of data facilitates the creation of an initial
population with selected markers that match an existing
sample, which usually contains markers from commer-
cially available genotyping platforms.
The first step of our simulation method is to create an
initial population from a real sample with selected mar-
kers. Depending on the application, one may want to
start from an existing GWA study with thousands of
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Trust Case Control Consortium [6], or from a publicly
available data set, such as Phase 2 or Phase 3 of the
HapMap data set [31]. Our study used 993 unrelated
individuals (parents in trio and duo samples and all unre-
lated individuals) in 10 populations of the Phase 3
HapMap data set because these data are readily available.
Depending on the specific application, markers can be
chosen according to markers used in real-world studies
(e.g., the markers on the Illumina 550k genotyping chip)
or by marker distance and minor allele frequency; indivi-
duals from one or more HapMap populations can be
selected either as separate populations or as a single
population.
We consider the initial populations as small, isolated
populations before the expansion of a typical human
population (around 12,000 years or 600 generations ago,
if we assume 20 years per generation with the invention
of agriculture) [33]. We then expand these populations
linearly to a larger population of 10
5 individuals by add-
ing the same number of individuals each year, subject to
mutation, recombination, and natural selection. We use
linear population expansion instead of a more com-
monly used exponential expansion model because a lin-
ear model expands the initial population faster at first,
thus better preserving genetic diversity in the initial
population and resulting in a final population with a lar-
ger effective population size. For example, if we start
with 993 individuals from the Phase 3 HapMap sample
and expand the population for 500 generations using
linear and exponential population expansion models, the
effective population sizes of the expanded populations
with 10
5 individuals would be 12,658 and 4603, respec-
tively [34]. The former is comparable to the effective
population size of real human populations.
During evolution, we mutate all SNP markers accord-
ing to a symmetric diallelic mutation model with a
mutation rate of 10
-8 per basepair per generation. At
each generation, parents are chosen at random and pass
their genotypes to offspring according to Mendelian
laws. Parental chromosomes are recombined according
to a fine-scale genetic map estimated from the HapMap
data set [35] before one of the recombinants is passed
to an offspring. If a selection model is specified, parents
are chosen with probabilities that are proportional to
their relative fitness values. Our simulation method sup-
ports both single-locus and multilocus natural selection
models, including models that involve multiple interact-
ing DPL. If multiple populations are simulated, a step-
ping stone migration model with a low migration rate is
applied to control the genetic distance between the
populations [36].
A scaling approach is used to improve the efficiency of
our simulation [37]. Compared to a regular simulation
that evolves a population of size N for t generations, a
scaled simulation with a scaling factor l evolves a smal-
ler population of size N/l for t/l generations with mag-
nified (multiplied by l) mutation, recombination, and
selection forces. This method could be justified by a dif-
fusion approximation to the standard Wright-Fisher
process [34,37]; however, because the diffusion approxi-
mation only applies to weak genetic forces in the evolu-
tion of haploid sequences, it cannot be used when
nonadditive diploid or strong genetic forces are used.
Our simulation program simulates populations with spe-
cified population size so a population simulated using a
scaling factor l would be comparable to an unscaled
simulation of a population that is l times larger.
To simulate a genetic disease, we control the frequen-
cies of DPAs at DPL using presimulated allele frequency
trajectories [21,38]. Either a forward-time approach or a
backward-time approach can be applied. More specifi-
cally, if we assume that a DPA existed before population
expansion, we simulate the frequency of the DPA for-
ward in time until it reaches the present generation.
The simulation starts from the frequency of the DPA in
the initial population and is restarted if the allele fre-
quency at the present generation falls out of the desired
range [24]. If the mutant is recent (e.g., appears within
the past 500 generations), we simulate from the fre-
quency of the DPA at the present generation backward
in time until the allele gets lost. Multilocus natural
selection models are supported with the restriction that
DPAs have to be unlinked. After the allele frequency
trajectories of DPAs are simulated, we use a special ran-
dom mating scheme to evolve the population forward in
time while following the simulated trajectories at these
loci [21]. This mating scheme simulates large intermedi-
ate populations and forms offspring populations with
desired allele frequencies by selecting offspring accord-
ing to their genotypes at controlled loci.
The final postprocessing step of the simulation pro-
cess will vary depending on the individual application.
To simulate a common disease with enough affected
individuals in the simulated population, we can draw
samples directly from the population after the affection
status of each individual is determined, usually using a
penetrance model that yields the probability that an
individual is affected with a disease according to his or
her genotype (Pr(affection status | genotype)). Alterna-
tively, a rejection-sampling algorithm could be used to
draw case-control samples or samples with independent
offspring (such as trios) of a rare disease. More specifi-
cally, we choose parents from the simulated population
and produce offspring repeatedly, apply the penetrance
model to determine the affection status of each off-
spring, and continue the process until enough samples
are collected.
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using several simuPOP scripts [29], including scripts to
download and select markers from Phase 2 and Phase 3
of the HapMap data set, a main script (simuGWAS.py)
to evolve a population forward in time with customiz-
able demographic and genetic features, and postproces-
sing scripts for the examples presented in this article.
The use of scripts in this implementation makes it easy
to adapt the examples for other simulations or even to
customize the evolutionary process using alternative
g e n e t i cf e a t u r e s .T h ea m o u n to ft i m er e q u i r e dt op e r -
form a simulation depends on the size of the simulation
and scales roughly linearly with the number of markers
and individuals. For example, the simulations in example
1 (5000 markers, using a scaling factor of 2 with a final
population size of 25000) and example 3 (500 markers,
unscaled) took 31 and 14 minutes, respectively, on a
Macintosh workstation with a 2.26-G Intel Xeon proces-
sor and 8 G of random access memory.
Results
Example 1: Typical simulations with or without scaling
We created an initial population with the 993 indepen-
dent individuals of the HapMap Phase 3 data set, using
5000 markers on region 2p16.3 (chr2:51002576-
60032817). This region spans 9.03 Mbp with a genetic
distance of 6.97 cM. It contains the ENr112 ENCODE
region and has an average marker distance of 1.81 kb.
We evolved this population for 500 generations until it
reached 50,000 individuals, subject to mutation (at a
mutation rate of 10
-8 per locus per generation), recom-
bination (according to the genetic distance between
adjacent markers), no selection, and linear population
expansion.
In order to evaluate the quality of simulated popula-
tions and the impact of the scaling technique, we simu-
lated three expanded populations of sizes 50000, 25000,
and 10000 using scaling factors 1 (unscaled), 2, and 5
respectively, and an expanded population of 50000 indi-
viduals using a scaling factor of 5. Whereas the first
three populations are scaled versions of the same evolu-
tionary process, the last one is comparable to an
unscaled simulation of a population of size 250000.
Compared to the first three simulations, genetic drift
has a smaller impact on the last simulation because of
its larger population sizes during evolution. This is
demonstrated in Figure 1 where the allele frequencies at
5000 markers for all simulated populations are com-
pared with those of the initial population.
The evolution of LD in such an evolutionary process
is more complicated. According to Figure 2, all simu-
lated populations had lower LD than those of the initial
population. Although populations simulated using a
scaling approach tended to have lower LD than those
from unscaled simulations, the differences between
mean R
2 values were negligible especially for markers
that are less than 200kbp apart. A more detailed analysis
showed that average LD increased and then decreased
during the evolutionary process of all simulations. This
phenomenon could be explained by the fact that our
simulation started from a relatively small population, so
LD first built up because of a bottleneck effect. With
increasing population size, the natural decay of LD
through genetic recombination gradually prevailed at a
rate accelerated by the impact of rapid population
expansion [39,40]. The simulation with a scaling factor
of 5 and population size 50000 had the lowest LD values
because it had a relatively short period of bottleneck and
a faster rate population expansion than other
simulations.
Example 2: A genetic disease with two DPL
We extracted 6000 markers (2000 markers each) on
chromosomes 2 (chr2:20014298-31200250), 5
(chr5:20005983-32781509) and 10 (chr10:41756307-
55305682) of 993 independent individuals from Phase 3
of the HapMap sample. We selected markers from a
commercially available genotyping chip (the Illumina
550k array) to match markers used in real-world
GWAS. The average distance between adjacent markers
was 5.61 kb. Two markers, rs4491689 (chr2:26494285)
and rs6869003 (chr5:27397573), were selected to be the
DPL of a genetic disease. The first marker was assumed
to be under purifying selection, with fitness values of 1,
0.996, and 0.994 for genotypes AA, AG, and GG, respec-
tively. The second marker was assumed to be under
positive selection, with fitness values of 1, 1.001, and
1.005 for genotypes CC, CT,a n dTT, respectively. A
multiplicative multilocus selection model was used.
Because these two loci reside on different chromosomes,
we considered natural selection to be applied to these
loci independently [41]. We assumed that the DPAs
existed longer than 500 generations, and we used a for-
ward-time simulation method to simulate trajectories of
the frequencies of the minor alleles at both loci, starting
from their frequencies in the chosen HapMap sample
(0.28 for marker rs4491689 and 0.07 for marker
rs6869003). The ending allele frequencies were 0.05 for
marker rs4491689 and 0.15 for marker rs6869003,
which were chosen in concordance with the selection
pressure that was applied to each marker. We did not
scale this simulation because of the use of a nonadditive
diploid selection model.
W eu s e dal o g i s t i cm o d e lw i t hg e n e - g e n ea n dg e n e -
environment interactions to model a disease that
involves these two genetic markers and a random envir-
onmental factor with two states 0 and 1. We assumed
that the disease was mild and was not the source of the
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expressed as logit (Pr(Y = 1|g1,g2,e)) = a+b1g1+b2g2+
b3g1g2+g1g1e+g1g1e + g2g2e where Y is the disease status,
g1 and g2 are number of DPAs at two markers respec-
tively, and e is the random environmental factor. This
model is an extension of the one-gene, one-environmen-
tal model used in Li and Conti [42]. We chose positi-
vea, bi,a n dgi values so that the presence of each DPA
increases the probability that an individual is affected
with the disease. We chose b1 = b2/2, g1 = g2/2, so that
the DPA at marker rs4491689 had less impact on the
disease than the DPA at marker rs6869003. Finally, we
controlled parameters a, bi,a n dgi so that the preva-
l e n c eo ft h ed i s e a s ew a s1 % .B e c a u s et h e r ew e r el e s s
than 1000 affected individuals in the expanded popula-
tion, we used a rejection-sampling algorithm to populate
an offspring population with exactly 1000 cases and
1000 controls from the expanded population.
We counted the number of alleles in cases and con-
trols, created a 2 by 2 contingency table and used a c
2
Figure 1 Allele frequencies of the initial (x-axis) and expanded (y-axis) populations of four simulations with populations sizes 50000,
25000, 10000 and 50000, and scaling factors l = 1 (unscaled), 2, 5 and 5 respectively.
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and alleles at each marker. The negative of the base 10
logarithm of the p-values at all markers were plotted in
Figure 3. Although the c
2 tests detected both genetic
factors correctly, more sophisticated statistical methods
or larger samples would be needed to detect the gene-
gene and gene-environment interactions in this data set.
Example 3: Simulations of slow and rapid selective sweep
In Example 2, natural selection was not expected to
have a strong impact on LD patterns around DPL
because it changed frequencies of both DPAs slowly
over a long period of time. In contrast, strong selection
can bring a new beneficial mutation to high frequency
or fixation in a population in a relatively short period of
time. This phenomenon, also called selective sweep, has
a profound impact on patterns of linked genetic varia-
tion through the hitchhiking effect. The signatures of
selective sweep have been used for the development of
statistical methods to identify chromosomal regions that
have been under positive selection [43] and for the iden-
tification of DPL in genome wide association analysis
[44]. Although theoretical models of selective sweep
have been simulated for methodological development
using coalescent approaches [43,45,46], explicit simula-
tion of selective sweep using a forward-time approach
can be used to study the impact of different levels of
natural selection on different regions of the human gen-
ome and to produce realistic samples to assess the
power of statistical methods.
In order to closely examine the impact of selective
sweep on existing LD patterns of a chromosomal region,
we extracted 500 markers on a short region on chromo-
some 2 (chr2:234157787-234573235) from 170 indepen-
dent individuals from the JPT+CHB population of Phase
3 of the HapMap data set. We selected this region
because it belongs to the ENr131 ENCODE region with
a mean distance of 0.83 kb between markers. We
selected marker rs2173746 with alleles C and T from
one of the two haplotype blocks in this region and
applied different levels of positive selection during the
evolution of this population.
In our first simulation, we assumed that allele T at this
marker was introduced more than 500 generations ago.
This allele had a frequency of 5.88% in the initial Hap-
Map population and reached a frequency of 99% after
500 generations due to positive natural selection with fit-
ness 1, 1.02, and 1.03 for genotypes CC, CT,a n dTT,
respectively. A forward-time trajectory simulation algo-
rithm was used to control the frequency of allele T at the
present generation. In our second simulation, we cleared
allele T at this marker from the initial population and
introduced it as a new mutant during the evolutionary
process. Using a backward-time trajectory simulation
process, an allele T was introduced at generation 268 and
was brought to a frequency of 99% using a stronger force
of natural selection with fitness 1, 1.05, and 1.11 for gen-
otypes CC, CT, and TT, respectively.
We drew 1000 trios from the simulated populations
using a rejection-sampling algorithm. More specifically,
we repeatedly chose parents and produced offspring.
We determined the affection status of each offspring
using a logistic regression model logot(Pr(Yi = 1))= -0.5-
gi, where gi is the number of allele T at locus rs2173746.
We kept only affected offspring and their parents in the
sample until 1000 trios were collected. We used LAMP
[47] to analyze the data set.
Figure 2 A v e r a g eL Dv a l u e sa saf u n c t i o no fm a r k e rd i s t a n c e
for the initial population and four expanded populations of
sizes 50000, 25000, 10000 and 50000, using scaling factors l =
1 (unscaled), 2, 5, and 5 respectively. The y-axis is plotted in log
scale to distinguish LD curves in low LD regions. Marker distances
were cut into bins of 10 kbp. For example, the average LD at point
200 kbp represents the mean pairwise LD values of all pairs of
markers that were 200 kbp to 210 kbp apart.
Figure 3 Negative of the base 10 logarithm of p-values of
allele-based c
2 tests between 1000 cases and 1000 controls at
6000 markers (2000 each) on chromosomes 2, 5, and 10.
Markers rs4491689 and rs6869003 are causal. Marker rs7720081 has
low p-value because it is closely linked to marker rs6869003.
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and 4C) as well as LD maps, drawn by HaploView [48],
of this region before evolution for all 500 markers (Fig-
ure 4A) and after evolution with slow (Figure 4D) and
rapid (Figure 4E) sweeps for 100 markers around the
DPL. The LD maps plot the pairwise D’ measure of LD
between all markers in a region, with high LD pairs
marked in bright red. Comparing the LD maps around
the DPL before (Figure 4A) and after evolution (Figure
4D and 4E), it was clear that rapid selective sweep intro-
duced blocks of monomorphic markers (gray areas
around marker rs2173746 in Figure 4E) when the haplo-
type with the mutant became prevalent when the
mutant (allele T at marker rs2173746) was brought to a
high frequency (99%). In contrast, the impact of slow
selective sweep on the LD patterns around the DPL was
barely discernible. As a matter of fact, the initial popula-
tion had 50 haplotypes over a region of 100 markers
around marker rs2173746 (50 markers on each side),
with a frequency of 16% for the most popular haplotype.
After rapid selective sweep, only 19 haplotypes existed
in this region, with a frequency of 97% for the most
popular haplotype. In contrast, 195 haplotypes were pre-
sent in the population resulting from slow selective
sweep, with a frequency of 44% for the most popular
haplotype.
The simulated populations could be used to test the per-
formance of statistical tests designed to detect signals of
positive selection along the human genome [43] and to
detect DPL if the DPA was under positive selection [44].
Figure 4 An initial population of 170 independent individuals of the JPT+CHB population of Phase 3 of the HapMap data set was
expanded to large populations and subjected to slow (B, D, F) and rapid (C, E, G) selective sweeps at locus rs2173746. The trajectories
of the frequencies of allele T at this marker in simulations after slow (B) and rapid (C) sweeps are plotted. The LD maps of 500 markers on
chromosome 2 of the initial population (A), and 100 markers around locus rs2173746 of expanded populations after the slow (D) and rapid (E)
sweeps are plotted. 1000 cases and 1000 controls were drawn from these expanded populations. The negative of the base 10 logarithm of
p-values at 500 markers are plotted for slow (F) and rapid (G) sweeps.
Peng and Amos BMC Bioinformatics 2010, 11:442
http://www.biomedcentral.com/1471-2105/11/442
Page 7 of 12For example, when we applied family-based association
tests to two samples of trio families drawn from the simu-
lated populations, the signals from rapid selective sweep
(Figure 4G) appeared to be wider than those from slow
selective sweep (Figure 4F). This phenomenon could be
explained by stronger LD between the DPL and its sur-
rounding loci for the simulation with rapid selective
sweep, but a quantitative analysis using a large number of
simulations would be needed to draw a definitive
conclusion.
Example 4: Simulation of admixed populations
Population structure has been known to cause spurious
associations in case-control association studies [49], so
several statistical methods have been developed to
reduce the impact of population structure on GWA stu-
dies [50-52]. On the other hand, population admixture
causes long-range admixture LD that could be used to
map diseases in admixed populations [53,54]. Although
simulations have been used to evaluate the performance
of these statistical methods, they have not been complex
enough to challenge the statistical methods under realis-
tic situations [3]. For example, Pfaff et al. [55] broke
existing LD of the founder populations from HapMap
samples by sampling alleles instead of haplotypes so that
only admixed LD existed in the simulated sample.
We aimed to simulate realistically admixed populations
by mixing populations simulated from the HapMap
populations. We extracted 5000 markers with minor
allele frequency greater than or equal to 0.05 from chro-
mosome 2 (chr2:50002476-60382263) using 170 and 143
independent individuals from the Phase 2 of the HapMap
Japanese in Tokyo, Japan and Han Chinese in Beijing,
China (JPT+CHB) and Maasai in Kinyawa, Kenya (MKK)
populations. The two populations were expanded to a
total size of 50,000 individuals. A low-level migration
rate of 0.0001 was applied to keep the genetic distance
between these two populations around its original level
of 0.11 (measured using FST) [56].
To control the levels of true LD and admixture LD, we
mixed large populations to avoid elevated LD caused by a
founder effect. We mixed these two populations using a
continuous gene flow model where 5% of individuals
from the MKK population migrated to the JPT+CHB
population for 10 generations [57]. At the beginning of
population mixing, we assigned an ancestral value of 0 to
individuals from the JPT+CHB population and a value of
1 for individuals from the MKK population. During the
admixture process, the offspring ancestral values were
recorded as the mean of parental ancestral values. We
used a positive assortative mating scheme to mix indivi-
duals because migrants usually do not mate randomly
with natives during a real-world admixture process, and
individuals would be efficiently mixed and have similar
ancestral values after only a few generations if the stan-
dard Wright-Fisher random mating process were used to
mix parents regardless of their ethnicity. More specifi-
cally, we divided individuals into two groups according to
their ancestral value, one with ancestral values greater
than or equal to 0.5 and another with ancestral values
less than 0.5. During the population of an offspring gen-
eration, 80% of all mating events happened within the
these two groups and the rest of the mating events hap-
pened with parents chosen randomly from the whole
population [58]. This process slowed down the admixture
process and resulted in a distribution of individual ances-
try values that is closer to that of real populations, such
as the mixture distribution of European ancestry among
all African Americans [59].
We applied to the population a penetrance model in
which individuals’ probability of being affected equals
0.05 + ancestry/6, where ancestry is the individual’s
MKK ancestry value. Individuals with higher MKK
ancestry values were more susceptible to this disease,
but none of the 5000 markers caused the disease
directly. Because there were enough affected individuals
in the simulated population, we drew 500 cases and 500
controls directly from the simulated population. We
used the STRUCTURE program to estimate the ancestry
values of cases and controls from their genotypes [50]
and plotted the estimated MKK ancestries against the
recorded ancestry values for each individual (Figure 5.a
and 5.b). Because individuals with high MKK ancestry
values are more likely to be affected, cases on average
had higher MKK ancestry values than controls.
In order to demonstrate the impact of population
structure on association analysis, we applied allele-based
c
2 tests and structured association tests proposed by
Pritchard et al. [60] to detect the association between
disease status and 2000 simulated markers (Figure 5.c
and 5.d). Although the disease is not directly caused by
any of the simulated markers, a large number of spur-
ious associations were detected by the c
2 tests. In con-
trast, the structured association tests estimated
individual ancestry values to control the impact of
population structure and successfully removed most
spurious associations.
Discussion
The genetic composition ofah u m a np o p u l a t i o ni st h e
result of a long and complex evolutionary process. The
demographic and genetic features of this process have
profound implications in the mapping of susceptibility
genes responsible for human genetic diseases [61].
Whereas resampling-based methods capture the com-
plexity of existing genome sequences with no control
over the impact of additional genetic and demographic
forces, and the coalescent methods simulate simple
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Page 8 of 12samples based solely on a few theoretical models, the
forward-time simulation method described in this article
retains key properties of human genomes by evolving a
population from real human sequences while allowing
the introduction of additional genetic forces such as nat-
ural selection. Because this method is not constrained by
any theoretical limit, it can be used to simulate realistic
samples for a variety of research topics for GWA
studies.
In order to retain key features of real human genomes
during evolution, this method expands the founder
population rapidly. Because the size of the founder
population is likely to be small, this evolutionary process
currently suffers from a bottleneck effect during the
initial stage of population expansion, resulting in a loss
of rare haplotypes and reduced genotype diversity. Dur-
ing rapid population expansion, common haplotypes are
maintained in the population with stable frequency,
whereas new haplotypes are constantly introduced by
mutation and recombination [41].
Consequently, common haplotypes in the initial popu-
lation are preserved in the simulated population, but
many rare haplotypes will be replaced by new haplo-
types. Because mutation has a relatively small impact on
common alleles, an increased mutation rate can be used
to generate more new haplotypes in the simulated popu-
lations without markedly affecting other population
properties such as allele frequency and LD patterns.
This limitation will become less of a challenge as more
human data become available (e.g., from the 1000
Genomes Project [32]).
Because a larger initial population size would reduce
the bottleneck effect and help preserve uncommon hap-
lotypes, we combined all independent individuals from
10 populations of the Phase 3 HapMap data set for
examples 1, 2, and 4. The sudden population admixture
caused long-range admixture LD in the combined initial
population. Such admixture LD decayed gradually dur-
ing evolution and did not lead to elevated long-range
LD in the simulated population (Figure 2). Nevertheless,
Figure 5 Ancestry values and p-values of association tests. The top figures plot recorded and estimated MKK ancestry values of 500 cases
(a) and 500 controls (b). Individuals are sorted by their true MKK ancestry values. The bottom figures plot the negative of the base 10 logarithm
of p-values of allele-based c
2 tests (c) and structured association tests (d) between 500 cases and 500 controls at 2000 markers.
Peng and Amos BMC Bioinformatics 2010, 11:442
http://www.biomedcentral.com/1471-2105/11/442
Page 9 of 12the availability of high-quality sequences of larger sam-
ples will allow us to generate population-specific sam-
ples and further improve the quality of our simulated
data sets.
We evaluated the quality of simulated data sets by
comparing allele frequency and LD patterns between the
simulated and the HapMap samples. However, we did
not attempt to tweak our evolutionary process so that
the simulated samples resembled the HapMap sample
closely because we aimed to simulate larger populations
with more genetic diversity than the founder population
and because we wanted to use a realistic evolutionary
process so that additional genetic or demographic fea-
tures could be added. If we consider the method to ran-
domly split and join pieces of chromosomes used by
HapSample [14] as a special form of recombination,
HapSample could be considered a one-generation for-
ward-time simulation method with magnified recombi-
nation rates. Our simulation method would yield results
similar to those of the resampling methods if we used
an extraordinarily high scaling factor so that all
sequences were essentially derived directly from haplo-
types of the initial population.
We used a fine-scale genetic map to determine the
recombination rate between adjacent markers [35]. This
map generally has a higher recombination rate between
markers from different haplotype blocks and a lower
recombination rate between markers from the same
haplotype blocks. Because recombinations happened
mostly between existing haplotype blocks, this genetic
map helped us retain the haplotype blocks and therefore
the LD structure of the founder population. However,
due to the relatively short evolutionary time, the type of
genetic map does not have a strong influence on the
simulated population. For example, there is no discern-
ible difference between LD patterns (e.g. Figure 2) of
simulated populations if we use a physical map with a
recombination rate of 0.01 per Mbp instead of a genetic
map to recombine parental chromosomes during evolu-
tion (results not shown).
Our simulation program allows the simulation of arbi-
trarily chosen selection models with multiple interacting
genetic factors and at the mean time allele frequencies
at the present generation. If inappropriate parameters
are chosen, it is likely that the specified selection model
would result in allele frequencies higher or lower than
expected so that no valid trajectory of allele frequency
could be simulated. If this is the case, our trajectory
simulation function will print the average ending fre-
quency for a forward-time simulation or length of tra-
jectory for a backward-time simulation so that the
simulation parameters can be adjusted accordingly. This
is especially useful if a gene-gene interaction model is
used so that marginal selection pressure can interact
with allele frequency and drive the allele frequency of
DPA in unpredictable directions.
Due to different requirements of different applications,
the flexibility of this simulation method is difficult to
harness using a traditional single-execution implementa-
tion. This is why we divided our simulation approach
into three steps and implemented different preproces-
sing and postprocessing scripts for different applications.
T h e s es c r i p t sw e r ew r i t t e ni nP y t h o na n dc a nb ee x e -
cuted on any platform where Python and simuPOP are
installed. The scripts provide both command line and
graphical user interfaces and could be used to simulate
samples for applications similar to those described in
this paper. For these reasons, it is relatively easy to
adapt these scripts for specific applications if different
evolutionary processes and/or processing procedures are
needed. We provide these scripts through a wiki-based
system (page simuGWAS in the “Complete Scripts” sec-
tion of the simuPOP online cookbook http://simupop.
sourceforge.net/cookbook) so that users can share their
experiences and improvements of this simulation
approach. We expect that more scripts will be contribu-
ted as users apply our proposed forward-time simulation
approach to a wider variety of GWA studies.
Conclusions
This paper describes a forward-time simulation algo-
rithm to simulate large populations from an initial
population that is created from selected markers of an
existing genetic sample. During rapid population expan-
sion, common haplotypes in the initial population are
well preserved, whereas new haplotypes are constantly
introduced by mutation and recombination, thus add
more genetic variations to the simulated population.
Compared to other simulation methods, our method
simulates samples with existing genetic markers that
resemble the human populations well in terms of mar-
ker allele frequency and LD structure, with additional
flexibility to simulate genomic regions with signals of
natural selection. Because of the use of a scripting lan-
guage design, our implementation of this algorithm can
simulate different types of samples with arbitrary disease
or quantitative trait models, making it an ideal tool to
evaluate the statistical power of a wide variety of statisti-
cal gene mapping methods for GWAS.
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